Journal
SCIENCE
Volume 351, Issue 6272, Pages 503-507Publisher
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.aad5589
Keywords
-
Categories
Funding
- NIH [HL091842, HL51670, HL117744, F30HL123239, 5T32GM007337, DK054759, K08HL097071]
- Cystic Fibrosis Foundation (University of Iowa Research Development Program) [OSTEDG1410, STOLTZ14XX0]
- Roy J. Carver Charitable Trust
- Gilead Sciences Research Scholars Program in Cystic Fibrosis
Ask authors/readers for more resources
Cystic fibrosis (CF) is caused by mutations in the gene that encodes the cystic fibrosis transmembrane conductance regulator (CFTR) anion channel. In humans and pigs, the loss of CFTR impairs respiratory host defenses, causing airway infection. But CF mice are spared. We found that in all three species, CFTR secreted bicarbonate into airway surface liquid. In humans and pigs lacking CFTR, unchecked H+ secretion by the nongastric H+/K+ adenosine triphosphatase (ATP12A) acidified airway surface liquid, which impaired airway host defenses. In contrast, mouse airways expressed little ATP12A and secreted minimal H+; consequently, airway surface liquid in CF and non-CF mice had similar pH. Inhibiting ATP12A reversed host defense abnormalities in human and pig airways. Conversely, expressing ATP12A in CF mouse airways acidified airway surface liquid, impaired defenses, and increased airway bacteria. These findings help explain why CF mice are protected from infection and nominate ATP12A as a potential therapeutic target for CF.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available